Concepedia

Prajakta Jogdand

PJ

8

Publications

452

Citations

8

H-Index

2006

Active since

Affiliations

Statens Serum Institut(Current)

University of Copenhagen

Lund University

Copenhagen University Hospital

Indian Institute of Integrative Medicine

Prajakta Jogdand is an author at Statens Serum Institut specializing in medicine, infection control, and t cell immunity.

Top concepts

MedicineAgingBiologyLongevityImmunologyMicrobiomeEngineeringVaccinationBacteriologyMicrobiology

Publications per year

2006–2020

8

Publications

8

Aging may be a conditional strategic choice and not an inevitable outcome for bacteria

Milind Watve, Sweta Parab, Prajakta Jogdand et al. · Proceedings of the National Academy of Sciences · 2006 · 147 citations · Full text

Engineering, Aging, Bacteriology +17

The Malaria Vaccine Candidate GMZ2 Elicits Functional Antibodies in Individuals From Malaria Endemic and Non-Endemic Areas

Micha Phill Grønholm Jepsen, Prajakta Jogdand, Susheel Kumar Singh et al. · The Journal of Infectious Diseases · 2013 · 69 citations

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate

Susana Lousada-Dietrich, Prajakta Jogdand, Søren Jepsen et al. · Vaccine · 2011 · 67 citations

Vaccination, Synthetic Tlr4 Agonist, Immunology +11

Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue

Prajakta Jogdand, Premkumar Siddhuraj, Michiko Mori et al. · European Respiratory Journal · 2020 · 55 citations · Full text

Basophil sensitivity reflects long‐term clinical outcome of subcutaneous immunotherapy in grass pollen‐allergic patients

Johannes Martin Schmid, Peter Adler Würtzen, Premkumar Siddhuraj et al. · Allergy · 2020 · 40 citations

Rows per page

1–5 of 8